Biggest News Aggregation in the World
📰 Ted Steiner News

Ted Steiner News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ted Steiner. Real-time updates on events, politics, business and more.

Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding

BURNABY, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce, in partnership with TransBIOTech (Quebec), being awarded an Applied Research and Development (ARD) grant via the College and Community Innovation (CCI) program administered through the Natural Sciences and Engineering Coun
United Kingdom Carole Ann Hupp Transbiotech Quebec Ted Steiner Hal Gunn Simon Sutcliffe
Source: yahoo.com

Diocesan officials call mass shooting at Nashville Presbyterian school 'sad, shocking,' urge prayers for victims, families

NASHVILLE, Tenn. (OSV News) -- Officials of the Nashville Diocese called news of a morning mass shooting and loss of life at a private Christian school in the city heartbreaking and deeply sad and shocking. Six individuals, including three children and school head Katherine Koonce, were fatally shot during the mid-morning hours March 27, at The Covenant School in the Green Hills neighborhood of Nashville. The private, Christian school educates students in preschool through sixth grade and was
United States Green Hills Davidson County Audreye Hale Evelyn Dieckhaus Rebecca Hammel

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Qu Biologics to Receive $6.7 Million in IRAP Funding to Support Innovative New Treatment to Restore Innate Immune Function in the Elderly

Qu Biologics to Receive $6.7 Million in IRAP Funding to Support Innovative New Treatment to Restore Innate Immune Function in the Elderly. Vancouver, BC, October 27, 2022--Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, announced that it is receiving advisory services and research and development funding of up to $6,659,050 from the National Research Cou...
British Columbia Hal Gunn Ted Steiner Qu Biologics Inc Site Specific Immunomodulators National Research Council

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science